FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084363 [Registered on: 08/04/2025] Trial Registered Prospectively
Last Modified On: 06/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of recovery of neuromuscular blockade of atracurium with neostigmine versus rocuronium with sugammadex in hepatopancreatic biliary surgeries - A Randomised Control Trial 
Scientific Title of Study   Comparison of recovery of neuromuscular blockade of atracurium with neostigmine versus rocuronium with sugammadex in hepatopancreatic biliary surgeries - A Randomised Control Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Lakshay Manchanda  
Designation  Senior resident, Department of Anaesthesia  
Affiliation  INSTITUTE OF LIVER AND BILIARY SCIENCES 
Address  E-62 second floor double storey Ramesh nagar

South West
DELHI
110015
India 
Phone  7011743941  
Fax    
Email  fdranzer@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Udit Dhingra  
Designation  Associate Professor 
Affiliation  INSTITUTE OF LIVER AND BILIARY SCIENCES  
Address  Department of Anaesthesia, Institute of Liver and Biliary Sciences, Vasant Kunj

South West
DELHI
110070
India 
Phone  8861987684  
Fax    
Email  uddh1989@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Udit Dhingra  
Designation  Associate Professor 
Affiliation  INSTITUTE OF LIVER AND BILIARY SCIENCES  
Address  Department of Anaesthesia, Institute of Liver and Biliary Sciences, Vasant Kunj

South West
DELHI
110070
India 
Phone  8861987684  
Fax    
Email  uddh1989@gmail.com  
 
Source of Monetary or Material Support  
Institute of Liver and Biliary Sciences, Vasant Kunj New Delhi 110070 
 
Primary Sponsor  
Name  Institute of Liver and Biliary sciences vasant kunj  
Address  D-1 vasant kunj New Delhi 110070 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Lakshay manchanda   INSTITUTE OF LIVER AND BILIARY SCIENCES  Department of anaesthesia, Institute of liver and biliary sciences vasant kunj New Delhi 110070
South West
DELHI 
7011743941

fdranzer@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute of liver and biliary sciences vasant kunj  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Patients undergoing major hepatopancreatic biliary surgeries 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Use of atracurium and reversal with neostigmine  To observe recovery of neuromuscular blockade of atracurium after administration of neostigmine and record time taken to achieve a train of four ratio 0.7 
Intervention  Use of rocuronium and reversal with sugammadex   To observe recovery of neuromuscular blockade of rocuronium after administration of sugammadex and record time taken to achieve a train of four ratio of 0.7 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Patients who give informed consent
Patients undergoing major hepatopancreatic biliary surgeries 
 
ExclusionCriteria 
Details  Patients with refusal to participate
Patients with neuromuscular weakness
Acidosis
Electrolyte abnormalities
Myesthenia gravis  
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Time taken to achieve Train of four ratio of 0.7  At 30 second intervals after giving reversal agent  
 
Secondary Outcome  
Outcome  TimePoints 
Time taken to achieve Train of four ratio 0.9
Heamodynamics during extubation
Time taken to pass first flatus  
Till post operative period 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   17/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  17/04/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Patients Undergoing major hepatopancreatic biliary surgeries will be given either atracurium for neuromuscular blockade followed by reversal with neostigmine Or rocuronium followed by reversal with sugammadex and time taken to recovery of blockade and heamodynamics will be noted at the end of surgery  
Close